BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 802 participants.

Also called NCT02341534

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 802 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02341534
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Hungary, Latvia, Netherlands, Poland, Slovakia, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02341534. Randomized; single masking; primary purpose diagnostic. Start 2015-08-07 (actual); primary completion 2021-11-03 (actual). Results posted on 2023-04-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction
Acronym
BIO-GUARD-MI
Condition
Myocardial Infarction, Acute
Condition
Myocardial Infarction Old
Intervention (Device)
BioMonitor
Lead sponsor
Biotronik SE & Co. KG (class: industry)
Collaborator
IHF GmbH - Institut für Herzinfarktforschung (class: other)
Collaborator
Qmed Consulting A/S (class: industry)

Record details

Record id
cardio:ct-nct02341534
Content hash
a14468c42c523ab1564b10836120454a223a7c7a6446a2111396e2e3e054cc3f